Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
While they can’t predict the future, financial advisors are placing their bets on active investments, quantum computing, and more.
As retail investors booms, advisors are balancing full-service offerings with more hands-on advice options.
Investors have plenty of choices to gain exposure to the Magnificent 7, depending on how much risk or reward they choose to take.